2016 - Vol. 3
Letter
| Requirements for human iPS cell-derived hepatocytes as an alternative to primary human hepatocytes for assessing absorption, distribution, metabolism, excretion and toxicity of pharmaceuticals | Vol.3, No.3, p.89-99 |
|---|---|
| Tetsuro Araki , Norihiko Iwazaki , Naoki Ishiguro , Atsushi Sakamoto , Keisuke Nagata , Masato Ohbuchi , Hiroyuki Moriguchi , Makiko Motoi , Raku Shinkyo , Toshiki Homma , Sakae Sakamoto , Yumiko Iwase , Ryota Ise , Yasuharu Nakanishi , Masahiro Uto , Tomoaki Inoue | |
| Released: April 05, 2016 | |